Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients

Clinical Breast Cancer

Volumn 2, Issue 4, 2002, Pages 311-315

  Benoy, Ina ^a   Salgado, Roberto ^a   Colpaert, Cecile ^a,b   Weytjens, Reinhilde ^a   Vermeulen, Peter B ^a,b   Dirix, Luc Y ^a  

^a SINT AUGUSTINUS HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Angiogenesis; Breast cancer; Plasma VEGF; Serum IL 6; Vegf

Indexed keywords

INTERLEUKIN 6; VASCULOTROPIN;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRANULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METASTASIS; PROTEIN EXPRESSION; STEM CELL; THROMBOCYTE;

EID: 0036188342     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2002.n.008     Document Type: Article

References (22)

1. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
2. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
3. Interleukin 6 induces the expression of vascular endothelial growth factor
4. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging?
5. Platelet: Transporter of vascular endothelial growth factor
6. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism
7. Molecular mechanisms linking thrombosis and angiogenesis in cancer
8. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
9. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
10. Tumour stimulating effects of recombinant human interleukin-6
11. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
12. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
13. Blood platelets and serum VEGF in cancer patients
14. Pitfalls in the measurement of circulating vascular endothelial growth factor
15. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
16. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer
17. Platelets and VEGF blood levels in cancer patients
18. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?
19. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma
20. Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis
21. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer
22. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo